HopeStage
Back to all studies
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study evaluates the safety and effectiveness of Aticaprant for people with depression.

Medication studyAges 18–74Multiple countries
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of Aticaprant for people with depression.

Who could participate?

Listed age limits: 18 years to 74 years.

Listed locations
Birmingham and 233 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 22, 2022
Recruitment status
Terminated
Enrollment listed in the registry
871
Sponsor
Janssen Research & Development, LLC
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Australia, France, ...
Age range
From 18 Years to 74 Years
Official registry ID
NCT05518149
Official title
Show the full official title

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Terminated

Birmingham, United States · Tucson, United States · Anaheim, United States

175 more locations
  • Culver City, United States
  • Glendale, United States
  • Lafayette, United States
  • Long Beach, United States
  • Oceanside, United States
  • Orange, United States
  • Rancho Cucamonga, United States
  • San Diego, United States
  • Santa Ana, United States
  • Santee, United States
  • Sherman Oaks, United States
  • Temecula, United States
  • Upland, United States
  • West Covina, United States
  • Colorado Springs, United States
  • Farmington, United States
  • Clearwater, United States
  • Coral Springs, United States
  • Fort Myers, United States
  • Gainesville, United States
  • Hialeah, United States
  • Maitland, United States
  • Miami, United States
  • Miami Gardens, United States
  • Miami Lakes, United States
  • North Bay Village, United States
  • Ocoee, United States
  • Orange City, United States
  • Orlando, United States
  • Pompano Beach, United States
  • Port Saint Lucie, United States
  • Tampa, United States
  • Berwyn, United States
  • Chicago, United States
  • Elgin, United States
  • Skokie, United States
  • Marrero, United States
  • Monroe, United States
  • Gaithersburg, United States
  • Methuen, United States
  • Ann Arbor, United States
  • O'Fallon, United States
  • Saint Charles, United States
  • Buffalo, United States
  • Mount Kisco, United States
  • New York, United States
  • Rochester, United States
  • The Bronx, United States
  • Charlotte, United States
  • Cincinnati, United States
  • Columbus, United States
  • Dayton, United States
  • Garfield Heights, United States
  • Edmond, United States
  • Oklahoma City, United States
  • Allentown, United States
  • Media, United States
  • Moosic, United States
  • Philadelphia, United States
  • Austin, United States
  • Bellaire, United States
  • Dallas, United States
  • Fort Worth, United States
  • Houston, United States
  • Katy, United States
  • Clinton, United States
  • Murray, United States
  • Charlottesville, United States
  • Bellevue, United States
  • Buenos Aires, Argentina
  • Ciudad Autonoma Buenos Aires, Argentina
  • Córdoba, Argentina
  • La Plata, Argentina
  • Mendoza, Argentina
  • Rosario, Argentina
  • San Miguel de Tucumán, Argentina
  • Santiago del Estero, Argentina
  • Frankston, Australia
  • Melbourne, Australia
  • Alken, Belgium
  • Brussels, Belgium
  • Duffel, Belgium
  • Sint-Niklaas, Belgium
  • Curitiba, Brazil
  • Fortaleza, Brazil
  • Goiânia, Brazil
  • Porto Alegre, Brazil
  • Rio de Janeiro, Brazil
  • São Bernardo, Brazil
  • São José do Rio Preto, Brazil
  • São Paulo, Brazil
  • Cherven Bryag, Bulgaria
  • Plovdiv, Bulgaria
  • Rousse, Bulgaria
  • Sofia, Bulgaria
  • Varna, Bulgaria
  • Veliko Tarnovo, Bulgaria
  • Sherbrooke, Canada
  • Baoding, China
  • Beijing, China
  • Changsha, China
  • Chengdu, China
  • Guangzhou, China
  • Huzhou, China
  • Shanghai, China
  • Shijiazhuang, China
  • Suzhou, China
  • Tianjin, China
  • Wuhan, China
  • Wuhu, China
  • Xi'an, China
  • Zhengzhou, China
  • Brno, Czechia
  • Klecany, Czechia
  • Kutná Hora, Czechia
  • Pilsen, Czechia
  • Prague, Czechia
  • Ústí nad Labem, Czechia
  • Bohars, France
  • Clermont-Ferrand, France
  • Douai, France
  • Nantes, France
  • Paris, France
  • Tours, France
  • Budapest, Hungary
  • Gyöngyös, Hungary
  • Kalocsa, Hungary
  • Pécs, Hungary
  • Szekszárd, Hungary
  • Bergamo, Italy
  • Catanzaro, Italy
  • Lecce, Italy
  • Milan, Italy
  • Siena, Italy
  • Bełchatów, Poland
  • Bialystok, Poland
  • Bydgoszcz, Poland
  • Gdansk, Poland
  • Katowice, Poland
  • Lodz, Poland
  • Poznan, Poland
  • Suchy Las, Poland
  • Torun, Poland
  • Braga, Portugal
  • Lisbon, Portugal
  • Banská Bystrica, Slovakia
  • Bojnice, Slovakia
  • Bratislava, Slovakia
  • Košice, Slovakia
  • Liptovský Mikuláš, Slovakia
  • Rimavská Sobota, Slovakia
  • Vranov nad Topľou, Slovakia
  • Cape Town, South Africa
  • Pretoria, South Africa
  • Strand, South Africa
  • Bucheon-si, South Korea
  • Busan, South Korea
  • Gyeonggi-do, South Korea
  • Seoul, South Korea
  • Barcelona, Spain
  • Madrid, Spain
  • Málaga, Spain
  • Palma de Mallorca, Spain
  • Ponferrada, Spain
  • Sabadell, Spain
  • Vigo, Spain
  • Vitoria-Gasteiz, Spain
  • Gothenburg, Sweden
  • Lund, Sweden
  • Stockholm, Sweden
  • Taichung, Taiwan
  • Taipei, Taiwan
  • London, United Kingdom
  • Southampton, United Kingdom
  • Czechia

A listed location does not confirm current availability.

FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of Aticaprant for people with depression.

Who is behind this study?

The study sponsor is Janssen Research & Development, LLC.

Does this study involve medication?

Yes. The study involves medication, including Aticaprant.

Who can participate?

Listed age limits: 18 years to 74 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies